Integra LifeSciences Holdings (IART)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 111,526 | 238,920 | 197,230 | 151,370 | 93,760 |
| Total assets | US$ in thousands | 3,781,990 | 3,889,760 | 3,782,380 | 3,615,140 | 3,303,240 |
| Operating ROA | 2.95% | 6.14% | 5.21% | 4.19% | 2.84% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $111,526K ÷ $3,781,990K
= 2.95%
Integra Lifesciences Holdings Corp's operating return on assets (operating ROA) has exhibited a fluctuating trend over the past five years. In 2023, the operating ROA decreased significantly to 2.95% compared to the previous year's level of 6.14%. This decline indicates a potential decrease in the company's ability to generate operating income from its assets.
Although the operating ROA for 2023 is lower than in 2022, it is still higher than the levels reported in 2021, 2020, and 2019, indicating that the company has historically been able to efficiently utilize its assets to generate operating income.
It is essential for Integra Lifesciences Holdings Corp to closely monitor and assess the factors contributing to the decrease in operating ROA in 2023 to identify opportunities for improvement and maintain or enhance asset efficiency in the future. Further analysis of the company's operational performance and asset management policies may provide insights into strategies to optimize operating ROA and enhance overall financial performance.
Peer comparison
Dec 31, 2023